Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...

Alan Osmond had been open about his 40-year battle with multiple sclerosis before his April 2026 death. Here is what he ...

An analysis of data from phase 3 randomized controlled trials showed that among individuals with comparable disease duration, inflammatory disease activity was significantly lower in older trial ...

The quest to understand and slow disease progression in multiple sclerosis (MS) continued in 2024, with research revealing possible new treatments and furthering knowledge about the disease course.

Ocrelizumab shows the highest association with urinary tract infections in patients with MS according to an FDA Adverse Event Reporting System analysis.

Usually referred to by the shorthand name MS, the disease shows up differently in people, but often includes fatigue, problems with memory and varying degrees of mobility impairment. For a while, ...

Tribute was paid to the star for his positive outlook and his encouragement to others on how to mentally and physically deal ...

Add Yahoo as a preferred source to see more of our stories on Google. PEORIA, Ill. (WMBD) — Three million people in the United States, around 20,000 people in Illinois, have Multiple Sclerosis. Mayo ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...

A new MS blood test from Roche has received EU approval and may help track disease activity by measuring nerve damage linked ...